Agreement enables development of genome-based therapies to protect against heart disease in adults

Innovations in repellent surfaces, generation of beta cells, zero-index metamaterials, robotic graspers, CRISPR-based diagnostics, cortistatin analogues, RNA-guided human genome engineering, and more

Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons

Innovations in reprogramming cells, compounds for activating killer T cells, polypeptides to modulate insulin receptors, analyte detection kits, slippery surfaces, and more